|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/06 | (2006.01) |
| C07K 16/46 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 2975051 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15181155.1 |
| Date of filing the European patent application | 2010-06-25 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-14 |
| (46) | Date of publication of the claims translation | 2021-07-12 |
| (30) | Number | Date | Country code |
| 220687 P | 2009-06-26 | US |
| (72) |
DAVIS, Samuel, US
SMITH, Eric, US
MACDONALD, Douglas, US
OLSON, Kara Louise, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Lengvai išskiriami bispecifiniai antikūnai su natyvios formos imunoglobulinu |
| READILY ISOLATED BISPECIFIC ANTIBODIES WITH NATIVE IMMUNOGLOBULIN FORMAT |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 16 | 347.00 EUR |
| 2026-06-25 |